At Bristol Myers Squibb, we are inspired by a single vision transforming patients lives through science. In oncology, hematology, immunology and cardiovascular disease and one of the most diverse and promising pipelines in the industry each of our passionate colleagues contribute to innovations that drive meaningful change. We bring a human touch to every treatment we pioneer. Join us and make a difference.
Position Summary
The primary role of the Downstream Manufacturing Engineering Intern is to provide documentation, equipment, and process support to the Manufacturing organization. The Intern may be the Manufacturing representative on projects and cross-functional teams, providing training, participating in the implementation of new equipment and processes, and supporting change control, bill of materials (BOM), and documentation changes. The position will start virtually with the option of on-site work if possible.
Key Responsibilities
* Support commercial process equipment installation and qualification.
* Develop visual learning content for document and process simplification.
* Support electronic format initiatives for paper reduction.
* Support manufacturing campaign readiness efforts as needed.
* Presentation of results from specific assignments at the conclusion of the internship via poster or electronic presentation to colleagues.
Qualifications & Experience
* Must be enrolled in school the semester of and/or during the assignment, as well as the semester following the assignment, with a 3.0+ GPA.
* Must be available to work full-time (40 hours/week) from early June 2021 to mid-August 2021.
* Qualified candidates will have completed sophomore, junior, senior or PhD level coursework towards a Biology, Chemistry, Engineering or related coursework.
* The ideal candidate will have:
* Strong analytical, interpersonal, communication, organization, technical writing, and project management skills, strong attention to detail.
* Demonstrated ability to present ideas, issues, and observations into a clear and useful format, and balance several projects in a fast-paced team environment.
* Demonstrated problem solving ability, interpersonal skills, and oral and written communication skills.
* Capability to collect, analyze, and integrate information by leveraging appropriate systems technology including MS Word, Excel, and PowerPoint.
* Understanding of Lean Manufacturing principals.
* Understanding of basic statistical analysis.
* Previous work experience in pharmaceuticals, biotechnology, or a related industry preferred.
* Work Environment: This position is an office-based position, supporting Manufacturing Operations. If working on site, the position may require varying levels of personal protective equipment (PPE) when in the manufacturing area. This position is based indoors and will be working primarily with others, but also independently at times.
* Physical Demands: Frequent repeated motions such as pipetting, lifting, bending, twisting, squatting, crouching, kneeling, climbing on step-stools, and reaching may be required. This role may also require frequent unassisted lifting (not to exceed 50 lbs). Repetitive use of arms/hands/wrists and grasping required. Office-based work requires sitting and frequent use of computers. Vision (acuity, color-correction allowed) required for interpretation of laboratory results.
Around the world, we are passionate about making an impact on the lives of patients with serious diseases. Empowered to apply our individual talents and diverse perspectives in an inclusive culture, our shared values of passion, innovation, urgency, accountability, inclusion and integrity bring out the highest potential of each of our colleagues.
Bristol Myers Squibb recognizes the importance of balance and flexibility in our work environment. We offer a wide variety of competitive benefits, services and programs that provide our employees with the resources to pursue their goals, both at work and in their personal lives.
Summit, NJ
Celgene Corporation, a biopharmaceutical company, discovers, develops, and commercializes therapies for the treatment of cancer and inflammatory diseases worldwide. It offers REVLIMID, an oral immunomodulatory drug for multiple myeloma (MM), myelodysplastic syndromes (MDS), and mantle cell lymphoma; POMALYST/IMNOVID to treat multiple myeloma; OTEZLA, a small-molecule inhibitor of phosphodiesterase 4 for psoriatic arthritis and psoriasis; and ABRAXANE to treat breast, non-small cell lung, pancreatic, and gastric cancers.
The company’s products also include IDHIFA for the treatment of adult patients with relapsed or refractory acute myeloid leukemia (rrAML) with an isocitrate dehydrogenase-2 mutation; VIDAZA, a pyrimidine nucleoside analog for intermediate-2 and high-risk MDS, chronic myelomonocytic leukemia, and AML; THALOMID to treat patients with MM; and ISTODAX, an epigenetic modifier. Its preclinical and clinical-stage product candidates include small molecules, biologics, and cell therapies for immune-inflammatory diseases, myeloid diseases, epigenetics, protein homeostasis, and immuno-oncology.
The company has agreements with BeiGene, Ltd; Acceleron Pharma, Inc.; Agios Pharmaceuticals, Inc.; bluebird bio, Inc.; Lycera Corp.; Juno Therapeutics, Inc.; EXSCIENTIA LTD.; and IMIDomics SL, as well as immuno-oncology collaboration with Sutro Biopharma. Celgene Corporation was founded in 1980 and is headquartered in Summit, New Jersey.